"We wish to launch an appeal to the future Government, to undertake a work of enhancement of the generic medicines sector, which today represents over 50 companies, with 5,000 employees and a turnover of 2 billion euros", he explained Giorgio Foresti, President of AssoGenerici. "As we have already declared during the recent meeting with the Antitrust, our sector needs an important action on the regulatory system, which offers it the possibility of developing within clear and shared rules and models. This must take place in quickly, in order not to weaken the generic system which, in the absence of significant market shares, will lose ground compared to brand companies and will have great difficulty resisting in Italy.The risk is that we will face an inevitable loss of investments and the flight of companies from Italy, with serious damage to the system". Aware of its representativeness and its associative strength, AssoGenerici is ready to intensify the collaboration and dialogue with the institutions, to ensure that the benefits deriving from the correct use of generic medicines can be perceived and enjoyed by all.
Source"Pharmacist33"
